| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
APOBEC mutagenesis and selection for NFE2L2 contribute to the origin of lung squamous-cell carcinoma
|
Cannataro, Vincent L.
|
|
|
171 |
C |
p. 34-41
|
artikel
|
| 2 |
Comparison of lung cancer aggressiveness in patients who never smoked compared to those who smoked
|
Adler, Shoshana
|
|
|
171 |
C |
p. 90-96
|
artikel
|
| 3 |
Concordance between clinical and pathology TNM-staging in lung cancer
|
Solberg, Steinar
|
|
|
171 |
C |
p. 65-69
|
artikel
|
| 4 |
Contents
|
|
|
|
171 |
C |
p. v-vi
|
artikel
|
| 5 |
Corrigendum to “Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma – Interpretation guidance derived from two randomized EORTC trials” [Lung Cancer 167C (2022) 65–72]
|
Koller, Michael
|
|
|
171 |
C |
p. 126
|
artikel
|
| 6 |
Editorial Board
|
|
|
|
171 |
C |
p. iii
|
artikel
|
| 7 |
Effect of adherence to treatment guidelines on overall survival in elderly non-small-cell lung cancer patients
|
Lindqvist, Jonatan
|
|
|
171 |
C |
p. 9-17
|
artikel
|
| 8 |
Erratum to “Predicting checkpoint inhibitors pneumonitis in non-small cell lung cancer using a dynamic online hypertension nomogram” [Lung Cancer 170 (2022) 74–84]
|
Jia, Xiaohui
|
|
|
171 |
C |
p. 121-125
|
artikel
|
| 9 |
Explaining differences in the frequency of lung cancer detection between the National Lung Screening Trial and community-based screening in Manchester, UK
|
Robbins, Hilary A.
|
|
|
171 |
C |
p. 61-64
|
artikel
|
| 10 |
Final overall survival data of sintilimab plus pemetrexed and platinum as First-Line treatment for locally advanced or metastatic nonsquamous NSCLC in the Phase 3 ORIENT-11 study
|
Zhang, Li
|
|
|
171 |
C |
p. 56-60
|
artikel
|
| 11 |
Genetic correlation of crizotinib efficacy and resistance in ALK- rearranged non-small-cell lung cancer
|
Liu, Chang
|
|
|
171 |
C |
p. 18-25
|
artikel
|
| 12 |
Investigation of the non-small cell lung cancer patients with uncertain resection: A population-based study
|
Wang, Xun
|
|
|
171 |
C |
p. 47-55
|
artikel
|
| 13 |
N-mytistoyltransferase 1 and 2 are potential tumor suppressors and novel targets of miR-182 in human non-small cell lung carcinomas
|
Zhang, Tong
|
|
|
171 |
C |
p. 70-81
|
artikel
|
| 14 |
Novel human-derived EML4-ALK fusion cell lines identify ribonucleotide reductase RRM2 as a target of activated ALK in NSCLC
|
Bokhari, A.A.
|
|
|
171 |
C |
p. 103-114
|
artikel
|
| 15 |
Olaparib as maintenance treatment in patients with chemosensitive small cell lung cancer (STOMP): A randomised, double-blind, placebo-controlled phase II trial
|
Woll, Penella
|
|
|
171 |
C |
p. 26-33
|
artikel
|
| 16 |
PD-L1 assessment in cytology samples predicts treatment response to checkpoint inhibitors in NSCLC
|
Lau, Sally C.M.
|
|
|
171 |
C |
p. 42-46
|
artikel
|
| 17 |
Pharmacokinetic boosting of osimertinib with cobicistat in patients with non-small cell lung cancer: The OSIBOOST trial
|
van Veelen, Ard
|
|
|
171 |
C |
p. 97-102
|
artikel
|
| 18 |
Prospective multicenter cohort study of durvalumab for patients with unresectable stage III non-small cell lung cancer and grade 1 radiation pneumonitis
|
Sugimoto, Takeya
|
|
|
171 |
C |
p. 3-8
|
artikel
|
| 19 |
Sex disparities in lung cancer survival rates based on screening status
|
Rodriguez Alvarez, Adriana A.
|
|
|
171 |
C |
p. 115-120
|
artikel
|
| 20 |
The changing landscape of pneumonitis in non-small cell lung cancer
|
Arifin, Andrew J.
|
|
|
171 |
C |
p. 1-2
|
artikel
|
| 21 |
Vascular invasion identifies the most aggressive histologic subset of stage I lung adenocarcinoma: Implications for adjuvant therapy
|
Yambayev, Ilyas
|
|
|
171 |
C |
p. 82-89
|
artikel
|
Tijdschrift beschrijving